The Indonesian government has said it is satisfied with the effectiveness of the Chinese COVID-19 vaccine it has been using, after China’s top disease control official said that current vaccines offer low protection against the novel coronavirus.
Siti Nadia Tarmizi, a spokesperson for Indonesia’s COVID-19 vaccine program, on Monday said the WHO had found that the Chinese vaccines had met requirements by being more than 50 percent effective.
Clinical trials in Indonesia for the vaccine from Chinese drugmaker Sinovac showed that it was 65 percent effective, she said.
“It means ... the ability to form antibodies in our bodies is still very good,” she added.
Researchers who conducted Sinovac’s clinical trials in Brazil released new data that confirmed the company’s previously announced efficacy rate of about 50 percent.
The paper, which was published on a Web site for scientists and has not yet been peer reviewed, showed that the vaccine was 50.7 percent effective against symptomatic COVID-19 cases and much stronger against severe ones.
Chinese Center for Disease Control and Prevention Director Gao Fu (高福) told a conference on Saturday that existing COVID-19 vaccines had low effectiveness rates and mixing vaccines is among strategies being considered to boost their effectiveness.
Those comments appeared to run counter to China’s official narrative that has tried to promote the country’s vaccines and at times discredit its Western counterparts.
China has distributed hundreds of millions of doses of domestically made vaccines abroad and is relying on them for its own mass immunization campaign.
Tarmizi said Indonesia would wait to see the results of any clinical trials before considering mixing vaccines.
“We are going to wait, waiting for the clinical trial to ensure the idea or innovation will have better effectiveness, immunogenicity, and efficacy level compared to the current condition,” she said.
Experts have said mixing vaccines, or sequential immunization, might boost effectiveness.
Researchers in the UK are studying a possible combination of the Pfizer and the AstraZeneca vaccines.
OUTRAGE: The former strongman was accused of corruption and responsibility for the killings of hundreds of thousands of political opponents during his time in office Indonesia yesterday awarded the title of national hero to late president Suharto, provoking outrage from rights groups who said the move was an attempt to whitewash decades of human rights abuses and corruption that took place during his 32 years in power. Suharto was a US ally during the Cold War who presided over decades of authoritarian rule, during which up to 1 million political opponents were killed, until he was toppled by protests in 1998. He was one of 10 people recognized by Indonesian President Prabowo Subianto in a televised ceremony held at the presidential palace in Jakarta to mark National
Philippine President Ferdinand Marcos Jr yesterday vowed that those behind bogus flood control projects would be arrested before Christmas, days after deadly back-to-back typhoons left swathes of the country underwater. Scores of construction firm owners, government officials and lawmakers — including Marcos’ cousin congressman — have been accused of pocketing funds for substandard or so-called “ghost” infrastructure projects. The Philippine Department of Finance has estimated the nation’s economy lost up to 118.5 billion pesos (US$2 billion) since 2023 due to corruption in flood control projects. Criminal cases against most of the people implicated are nearly complete, Marcos told reporters. “We don’t file cases for
Ecuadorans are today to vote on whether to allow the return of foreign military bases and the drafting of a new constitution that could give the country’s president more power. Voters are to decide on the presence of foreign military bases, which have been banned on Ecuadoran soil since 2008. A “yes” vote would likely bring the return of the US military to the Manta air base on the Pacific coast — once a hub for US anti-drug operations. Other questions concern ending public funding for political parties, reducing the number of lawmakers and creating an elected body that would
LANDMARK: After first meeting Trump in Riyadh in May, al-Sharaa’s visit to the White House today would be the first by a Syrian leader since the country’s independence Syrian President Ahmed al-Sharaa arrived in the US on Saturday for a landmark official visit, his country’s state news agency SANA reported, a day after Washington removed him from a terrorism blacklist. Sharaa, whose rebel forces ousted long-time former Syrian president Bashar al-Assad late last year, is due to meet US President Donald Trump at the White House today. It is the first such visit by a Syrian president since the country’s independence in 1946, according to analysts. The interim leader met Trump for the first time in Riyadh during the US president’s regional tour in May. US envoy to Syria Tom Barrack earlier
RSS